Login to Your Account

Washington Roundup

Committee to Ponder Tumor Cells for Vaccine Manufacture

By Catherine Shaffer
Staff Writer

Wednesday, September 19, 2012
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) released briefing documents in advance of its Wednesday meeting to discuss the use of cell lines derived from human tumors for vaccine manufacture.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription